Positive impact of liraglutide on pulmonary function in patients with type 2 diabetes: data from the randomised cross-over LIRALUNG study
Por:
Lopez-Cano, C, Ciudin, A, Sanchez, E, Tinahones, F, Soto, A, Pellitero, S, Barbe, F, Dalmases, M, Garcia-Ramirez, M, Gaeta, A, Marti, R, Hernandez, C, Simo, R and Lecube, A
Publicada:
1 sep 2021
Resumen:
Filiaciones:
Lopez-Cano, C:
Hosp Arnau Vilanova, Endocrinol & Nutr, Lleida, Spain
Ciudin, A:
Hosp Univ Vall dHebron, Endocrinol & Nutr, Barcelona, Spain
Sanchez, E:
Hosp Arnau Vilanova, Endocrinol & Nutr, Lleida, Spain
Tinahones, F:
Hosp Univ Virgen Victoria, Endocrinol & Nutr, Malaga, Spain
Soto, A:
Hosp Univ A Coruna, Endocrinol & Nutr, La Coruna, Spain
:
Hosp Univ Germans Trias i Pujol, Endocrinol & Nutr, Badalona, Spain
Barbe, F:
Hosp Arnau Vilanova, Pneumol, Lleida, Spain
Dalmases, M:
Hosp Arnau Vilanova, Pneumol, Lleida, Spain
Garcia-Ramirez, M:
Hosp Univ Vall dHebron, Endocrinol & Nutr, Barcelona, Spain
Gaeta, A:
Hosp Arnau Vilanova, Pneumol, Lleida, Spain
Marti, R:
Hosp Arnau Vilanova, Endocrinol & Nutr, Lleida, Spain
Hernandez, C:
Hosp Univ Vall dHebron, Endocrinol & Nutr, Barcelona, Spain
Simo, R:
Hosp Univ Vall dHebron, Endocrinol & Nutr, Barcelona, Spain
Lecube, A:
Hosp Arnau Vilanova, Endocrinol & Nutr, Lleida, Spain
|